Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, May 21, 2025 — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for…


